怀孕期间生活方式干预对妊娠糖尿病的影响:个体参与者数据和网络元分析
John Allotey1, Dyuti Coomar2, Joie Ensor3,4
1Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, UK.
概括
生活方式干预有效地预防妊娠期糖尿病,特别是在使用IADPSG标准时. 基于体育活动的计划和小组形式显示出降低风险的最大希望.
科学领域:
- 产科和妇科 产科和妇科
- 内分泌学 在内分泌学.
- 公共卫生 公共卫生
背景情况:
- 孕期糖尿病 (GDM) 在怀孕期间越来越令人担忧.
- 生活方式干预是GDM预防和管理的关键策略.
- 了解各种干预措施的有效性和影响因素对于公共卫生倡议至关重要.
研究的目的:
- 评估生活方式干预措施对预防妊娠糖尿病的影响.
- 根据母亲的特征 (BMI,年龄,种族,教育) 和干预类型来确定干预效应是否不同.
- 根据其在预防GDM方面的有效性对生活方式干预进行排名.
主要方法:
- 一个双阶段的个人参与者数据 (IPD) 分析与网络分析相结合.
- 包括104个随机试验 (35,993名女性) 与IPD68%的参与者.
- 使用各种标准 (任何标准,英国NICE,IADPSG) 评估GDM,并分析了子组效应和干预排名.
主要成果:
- 使用任何标准,生活方式干预降低了20%的GDM (组合数据),使用IADPSG标准降低了18%.
- 干预的有效性并没有因大多数母亲的特征而有显著差异,但在受教育程度较低的妇女中表现较差.
- 由新培训的辅导员领导的以小组为基础的格式和干预措施更有效;以身体活动为基础的干预措施排名最高.
结论:
- 生活方式干预在预防妊娠期糖尿病方面是有效的,根据诊断标准的不同影响.
- 实施应解决教育不平等问题,并优先考虑团体格式,训练有素的辅导员和体育活动干预措施.
- 这些发现支持针对不同人群的GDM预防的有针对性的策略.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
4.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.3K
Pathophysiology of Diabetes
3.1K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.1K
Oral Hypoglycemic Agents: Biguanides and Glitazones
581
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
581
Dipeptidyl Peptidase 4 Inhibitors
575
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
575
Diabetes: Management and Pharmacotherapy
858
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
858
Diabetes Mellitus: Overview and Type I Subtype
4.8K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.8K


